TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16850022

Group type: EXPERIMENTAL
Intervention: Continuous veno‐venous hemodiafiltration (CVVHDF) (1‐2.5 l/h replacement fluid + 1‐1.5 l/h dialysate)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Continuous veno‐venous hemofiltration (CVVH) (1‐2.5 l/h replacement fluid)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Continuous veno‐venous hemodiafiltration (CVVHDF)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Continuous veno‐venous hemofiltration (CVVH)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: CVVH and CVVHDF
Number of subjects: 206
Study: 14764999

Group type: EXPERIMENTAL
Intervention: Auditory n-back task (assessing storage and rehearsal/maintenance)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paced Auditory Serial Addition Task (with significant central executive component)
Number of subjects: 0
Study: 10340958

Group type: EXPERIMENTAL
Intervention: Intra-articular injection of 40 mg anti-CD4
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Intra-articular injection of 0.4 mg anti-CD4
Number of subjects: 13

Group type: COMPARATOR
Intervention: Intra-articular injection of placebo
Number of subjects: 13
Study: 8654059

Group type: EXPERIMENTAL
Intervention: Detoxified alcohol-dependent patients
Number of subjects: 521

Group type: EXPERIMENTAL
Intervention: Age of onset of alcoholism
Number of subjects: 521

Group type: EXPERIMENTAL
Intervention: Anxiety state, anxiety trait, and sex
Number of subjects: 521
Study: 1497228

Group type: EXPERIMENTAL
Intervention: Diabetic children and adolescents with poor metabolic control
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Diabetic children and adolescents with prolonged evolution of diabetes
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Pubertal diabetic patients
Number of subjects: 68

Group type: COMPARATOR
Intervention: Healthy children of the same ages
Number of subjects: 68
Study: 6702616

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 30 mg/day
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 120 mg/day
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 240 mg/day
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 480 mg/day
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 31242943

Group type: EXPERIMENTAL
Intervention: Low-dose methotrexate (MTX)
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: LINE-1 elements
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Changes in global DNA (hydroxy)methylation
Number of subjects: 294
Study: 29794523

Group type: EXPERIMENTAL
Intervention: Simultaneous condition
Number of subjects: 87

Group type: COMPARATOR
Intervention: Sequential condition
Number of subjects: 87
Study: 26995378

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (2.5 mg twice daily) + P2Y12 inhibitor
Number of subjects: 3000

Group type: COMPARATOR
Intervention: DAPT (Aspirin 100 mg + P2Y12 inhibitor)
Number of subjects: 3000
Study: 25174319

Group type: EXPERIMENTAL
Intervention: Modified endoscopic operation
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (osteotome operation)
Number of subjects: 6
Study: 22009916

Group type: EXPERIMENTAL
Intervention: Lutein (10 mg), zeaxanthin (1 mg), astaxanthin (4 mg) and antioxidants/vitamins supplementation formula
Number of subjects: 145

Group type: COMPARATOR
Intervention: No dietary supplementation
Number of subjects: 145
Study: 19560695

Group type: EXPERIMENTAL
Intervention: Milrinone (0.05 mg/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (high dose: 0.43 mg/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (low dose: 0.05 mg/kg)
Number of subjects: 30
Study: 16480759

Group type: EXPERIMENTAL
Intervention: 12-week calorie restricted diet
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Diet with aerobic exercise
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (non-obese subjects)
Number of subjects: 86
Study: 16271149

Group type: EXPERIMENTAL
Intervention: Motor control exercise
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo (detuned short wave and detuned ultrasound)
Number of subjects: 154
Study: 14562530

Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 98

Group type: COMPARATOR
Intervention: Three day cotrimoxazole
Number of subjects: 98

Group type: COMPARATOR
Intervention: Five day cotrimoxazole
Number of subjects: 98
Study: 10432067

Group type: EXPERIMENTAL
Intervention: Low-dose mefloquine-sulfadoxine-pyrimethamine (MSP)
Number of subjects: 1935

Group type: COMPARATOR
Intervention: Chloroquine (CQ)
Number of subjects: 1935
Study: 7774210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 457
Study: 2182697

Group type: EXPERIMENTAL
Intervention: Salbutamol, 2.5 mg administered by nebulization
Number of subjects: 9
Study: 217694

Group type: EXPERIMENTAL
Intervention: Polyenyl phosphatidyl choline (PPC) plus clofibrate
Number of subjects: 67

Group type: COMPARATOR
Intervention: Clofibate
Number of subjects: 67
Study: 31366325

Group type: EXPERIMENTAL
Intervention: McGrath® MAC videolaryngoscopic intubation with a stylet (group S, n=52)
Number of subjects: 104

Group type: COMPARATOR
Intervention: McGrath® MAC videolaryngoscopic intubation without a stylet (group N, n=52)
Number of subjects: 104
Study: 28064524

Group type: EXPERIMENTAL
Intervention: Teaser Campaign (branded promotional postcards)
Number of subjects: 744

Group type: COMPARATOR
Intervention: Standard Mail (no postcards)
Number of subjects: 744

Group type: EXPERIMENTAL
Intervention: Teaser Campaign
Number of subjects: 744

Group type: EXPERIMENTAL
Intervention: Physiotherapy clinics (Teaser Campaign)
Number of subjects: 744

Group type: EXPERIMENTAL
Intervention: General practice clinics (Teaser Campaign)
Number of subjects: 744
Study: 25868409

Group type: EXPERIMENTAL
Intervention: Noncontact low-frequency ultrasound (NLFU) + Standard Care (SC)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 27
Study: 23792486

Group type: EXPERIMENTAL
Intervention: Sham injection + prompt laser with green laser treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sham injection + prompt laser with yellow laser treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ranibizumab + prompt laser
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prompt laser only
Number of subjects: 0
Study: 21719865

Group type: EXPERIMENTAL
Intervention: Injectable poly-L-lactic acid (PLLA)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Human collagen
Number of subjects: 233
Study: 19542420

Group type: EXPERIMENTAL
Intervention: Metallic stent placement for gastric carcinoma
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Metallic stent placement for pancreatic carcinoma
Number of subjects: 207
Study: 16409329

Group type: EXPERIMENTAL
Intervention: Ca(OH)(2)/CHX (gel)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ca(OH)(2)/CHX (solution)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ca(OH)(2)/saline paste
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Patency file used
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Patency file not used
Number of subjects: 64
Study: 12115589

Group type: EXPERIMENTAL
Intervention: Dietary consultation aimed at reducing salt and increasing vitamin C and carotenes over 1 year
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (no dietary intervention)
Number of subjects: 59
Study: 9932568

Group type: EXPERIMENTAL
Intervention: Extra-amniotic saline infusion
Number of subjects: 52

Group type: COMPARATOR
Intervention: Intracervical dinoprostone gel
Number of subjects: 52
Study: 7479199

Group type: EXPERIMENTAL
Intervention: Single, oral, 20‐mg dose of glipizide
Number of subjects: 6

Group type: COMPARATOR
Intervention: Divided-dose regimens totaling 20 mg each (simulating delayed absorption over 2, 4, and 8 hours)
Number of subjects: 6
Study: 2215093

Group type: EXPERIMENTAL
Intervention: Surecut 0.6 mm liver biopsy
Number of subjects: 77

Group type: COMPARATOR
Intervention: Menghini biopsy
Number of subjects: 77
Study: 378734

Group type: EXPERIMENTAL
Intervention: Orphenadrine (25 mg) and acetaminophen (325 mg) combination
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Orphenadrine (25 mg) alone
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Acetaminophen (325 mg) alone
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 31923642

Group type: EXPERIMENTAL
Intervention: Risk score (0-15) derived from factors including age, smoking habits, family history of colorectal cancer, and presence of neoplasia in the distal colorectum.
Number of subjects: 7954

Group type: EXPERIMENTAL
Intervention: Risk score of 4 points or higher indicating high risk for APN.
Number of subjects: 7954

Group type: EXPERIMENTAL
Intervention: C-statistic of the scoring system.
Number of subjects: 7954

Group type: EXPERIMENTAL
Intervention: Number needed to refer based on scoring system.
Number of subjects: 7954

Group type: EXPERIMENTAL
Intervention: Number needed to screen based on scoring system.
Number of subjects: 7954
Study: 30134294

Group type: EXPERIMENTAL
Intervention: Streamlined HIV care delivery model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ART (TDF/3TC/EFV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Viral load testing (2 tests/year)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimized ART scale-up with lowest-cost ART
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Annual viral load testing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Governmental healthcare worker salaries
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Streamlined care delivery costs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Retention in care and viral suppression levels
Number of subjects: 0
Study: 27780932

Group type: EXPERIMENTAL
Intervention: High sPDL1 (≥0.94 ng/mL)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Low sPDL1 (<0.94 ng/mL)
Number of subjects: 158
Study: 26419096

Group type: EXPERIMENTAL
Intervention: ORS group (1,500 ml ORS 6 to 2 hours before anesthesia)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (nothing by mouth from 6 hours before anesthesia)
Number of subjects: 40
Study: 23916551

Group type: EXPERIMENTAL
Intervention: 320‐section volume imaging using AIDR (group A)
Number of subjects: 150

Group type: COMPARATOR
Intervention: 320‐slice volume scan without AIDR (group B)
Number of subjects: 150

Group type: COMPARATOR
Intervention: 64‐section helical imaging without AIDR (group C)
Number of subjects: 150
Study: 20152024

Group type: EXPERIMENTAL
Intervention: IP6 + Inositol
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 19017850

Group type: EXPERIMENTAL
Intervention: Custom-made foot orthoses
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Prefabricated shoe inserts
Number of subjects: 40

Group type: COMPARATOR
Intervention: Prefabricated shoe inserts after custom-made orthoses
Number of subjects: 40
Study: 17079221

Group type: EXPERIMENTAL
Intervention: Children with SLI
Number of subjects: 0

Group type: COMPARATOR
Intervention: Syntactic complexity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphological complexity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Complexity of stimuli
Number of subjects: 0
Study: 12841541

Group type: EXPERIMENTAL
Intervention: GHRH + GH-releasing peptide-6 (GHRP-6)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Fasting
Number of subjects: 21
Study: 10225245

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 72

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 72
Study: 8665876

Group type: EXPERIMENTAL
Intervention: Pre‐emptive ketorolac 30 mg administered 30 min before surgical incision
Number of subjects: 77

Group type: COMPARATOR
Intervention: Post‐surgical ketorolac 30 mg administered at the end of the surgical procedure
Number of subjects: 77
Study: 2194133

Group type: EXPERIMENTAL
Intervention: Thymopentin (50 mg subcutaneously twice per week for 3 weeks, followed by 1 intramuscular injection of 40 micrograms HB-Vax and 3 subsequent injections of thymopentin)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 346252

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide plus timolol
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide plus timolol plus hydralazine
Number of subjects: 38

Group type: COMPARATOR
Intervention: Hydrochlorothiazide plus placebo plus hydralazine
Number of subjects: 38
Study: 31319174

Group type: EXPERIMENTAL
Intervention: Acute exercise during HPV vaccination
Number of subjects: 0

Group type: COMPARATOR
Intervention: No exercise during HPV vaccination
Number of subjects: 0
Study: 27997472

Group type: EXPERIMENTAL
Intervention: Facilitated mobilization (staff dedicated to assist transfers and walking from postoperative days 0-3)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Facilitated mobilization
Number of subjects: 99

Group type: COMPARATOR
Intervention: Usual care (including preoperative education about early mobilization with postoperative daily targets)
Number of subjects: 99
Study: 26718606

Group type: EXPERIMENTAL
Intervention: Luseogliflozin (2.5 mg/d, increased to 5 mg/d)
Number of subjects: 1030

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1030

Group type: EXPERIMENTAL
Intervention: Luseogliflozin
Number of subjects: 1030
Study: 23875789

Group type: EXPERIMENTAL
Intervention: Teflon tape technique
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pull-through technique
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bioclear matrix technique
Number of subjects: 60

Group type: COMPARATOR
Intervention: All techniques
Number of subjects: 60
Study: 21844885

Group type: EXPERIMENTAL
Intervention: FOLFIRI + bevacizumab
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: XELIRI + bevacizumab
Number of subjects: 173
Study: 19608110

Group type: EXPERIMENTAL
Intervention: Emotional photos
Number of subjects: 74

Group type: COMPARATOR
Intervention: Calm photos
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Participants with significant differential effects in pupillary dilation
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Varying probability of observing future images
Number of subjects: 74
Study: 17720628

Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paradoxical therapy
Number of subjects: 0
Study: 15165412

Group type: EXPERIMENTAL
Intervention: Experimental test (stimulated subjects)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control test (no humans present)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Stimulated subjects' event‐related potentials
Number of subjects: 26
Study: 12126525

Group type: EXPERIMENTAL
Intervention: Prednisone group (14 cases) treated by methimazole 15 approximately 30 mg/d, propranolol 15 approximately 30 mg/d, and prednisone 30 mg/d
Number of subjects: 24

Group type: COMPARATOR
Intervention: Traditional antithyroid group (10 cases) treated by methimazole 15 approximately 30 mg/d and propranolol 15 approximately 30 mg/d
Number of subjects: 24
Study: 9533674

Group type: EXPERIMENTAL
Intervention: Cochrane Collaboration systematic reviews
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cochrane Collaborative Review Group for Headache
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incorporating evidence into treatment guidelines
Number of subjects: 0
Study: 7491854

Group type: EXPERIMENTAL
Intervention: GyneFix (frameless, flexible IUD)
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: GyneFix
Number of subjects: 10000
Study: 28885671

Group type: EXPERIMENTAL
Intervention: 1 horizontal muscle surgery (group 1)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 1 oblique muscle surgery (group 2)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 2 horizontal muscle surgeries (group 3)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 1 horizontal and 1 oblique muscle surgery (group 4)
Number of subjects: 37
Study: 27607876

Group type: EXPERIMENTAL
Intervention: Exercise intervention (14-week supervised home-based stationary cycling program)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 172
Study: 25645325

Group type: EXPERIMENTAL
Intervention: Growth hormone (Norditropin(®) SimpleXx)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Baseline (Turner syndrome)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Controls (age-matched females)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Growth hormone treatment
Number of subjects: 9
Study: 23013207

Group type: EXPERIMENTAL
Intervention: ETN 50 mg BIW for 12 weeks followed by QW for 12 weeks (BIW/QW group)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: ETN 50 mg QW for 24 weeks (QW/QW group)
Number of subjects: 72
Study: 22052313

Group type: EXPERIMENTAL
Intervention: Hair Stimulating Complex (HSC)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 19371492

Group type: EXPERIMENTAL
Intervention: Motivational interviewing with personalized feedback (MI)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Personalized feedback only (Control)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Both treatment groups (MI and Control)
Number of subjects: 215
Study: 16941666

Group type: EXPERIMENTAL
Intervention: Clinical teaching (31%)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Psycho-educational teaching (27%)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Supportive counseling (33%)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Psychosocial counseling (9%)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Counseling model sessions
Number of subjects: 177
Study: 15203476

Group type: EXPERIMENTAL
Intervention: Literature and medicine elective course (8 sessions)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Wait-list group (control)
Number of subjects: 22
Study: 11307260

Group type: EXPERIMENTAL
Intervention: 5.25% NaOCl
Number of subjects: 100

Group type: COMPARATOR
Intervention: Initial-saline
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 0.5% NaOCl
Number of subjects: 100
Study: 9709280

Group type: EXPERIMENTAL
Intervention: Mammographic screening
Number of subjects: 160000

Group type: EXPERIMENTAL
Intervention: Regular screening of 10,000 women aged 40-49
Number of subjects: 160000
Study: 8513844

Group type: EXPERIMENTAL
Intervention: Application of the tablet to the gingiva
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Application of the tablet to the palate
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Application of the tablet to the cheek
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Application of the tablet to the cheek in comatose intubated patients
Number of subjects: 10
Study: 3552302

Group type: EXPERIMENTAL
Intervention: Hydralazine and isosorbide dinitrate
Number of subjects: 642

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 642

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 642
Study: 30356057

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with a standardised anaesthetic regimen (ACU)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Acupressure (APU)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (standard anaesthesia alone, CON)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Acupuncture (ACU) and Acupressure (APU)
Number of subjects: 75
Study: 27296848

Group type: EXPERIMENTAL
Intervention: Fractional third dose (Fx017M)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Full-dose regimen (012M)
Number of subjects: 46
Study: 24754142

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (10 mg orally daily for 14 days)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo (oral)
Number of subjects: 88
Study: 22261830

Group type: EXPERIMENTAL
Intervention: Voluntary counseling/testing (VC/T) with drug treatment referral
Number of subjects: 1030

Group type: COMPARATOR
Intervention: Voluntary counseling/testing (VC/T), referral, and brief motivational intervention (B-MI)
Number of subjects: 1030
Study: 19779855

Group type: EXPERIMENTAL
Intervention: Brief motivational enhancement intervention
Number of subjects: 143

Group type: COMPARATOR
Intervention: Standard treatment (Control)
Number of subjects: 143
Study: 18502603

Group type: EXPERIMENTAL
Intervention: GABI scale
Number of subjects: 106

Group type: COMPARATOR
Intervention: Standard scales (ADL, IADL, AGGIR, Barthel)
Number of subjects: 106
Study: 15825070

Group type: EXPERIMENTAL
Intervention: Infliximab maintenance treatment (5 mg/kg every 8 weeks)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Placebo maintenance
Number of subjects: 282
Study: 12231656

Group type: EXPERIMENTAL
Intervention: 3 mmHg pressure step protocol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10 mmHg pressure step protocol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 3 mmHg pressure step after transient venous decongestion
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10 mmHg pressure step after transient venous decongestion
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 3 mmHg pressure step after transient deflation
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10 mmHg pressure step after transient deflation
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Transient pressure reduction
Number of subjects: 18
Study: 10512939

Group type: EXPERIMENTAL
Intervention: Tension-free laparoscopic hernia repair (LHR)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Open hernia repair (OHR)
Number of subjects: 105
Study: 8770666

Group type: EXPERIMENTAL
Intervention: SIN-1 (linsidomine chlorhydrate)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: SIN-1 plus Urapidil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Prostaglandin E1 (PGE1)
Number of subjects: 40
Study: 1952266

Group type: EXPERIMENTAL
Intervention: Methacholine (MC) subcutaneous injections
Number of subjects: 31

Group type: COMPARATOR
Intervention: Atropine (AT) subcutaneous injections
Number of subjects: 31

Group type: COMPARATOR
Intervention: Multi-electrolyte solution (MES) injections
Number of subjects: 31

Group type: COMPARATOR
Intervention: AT-containing lotion
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: MC-containing lotion
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: MES solution
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: MES solution with MC addition
Number of subjects: 31

Group type: COMPARATOR
Intervention: MES solution with AT addition
Number of subjects: 31